Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventriculography with metrizamide in children.

R D Strand1, R A Baker

  • 1Department of Radiology, Children's Hospital Medical Center, Boston, Massachusetts.

Acta Radiologica. Supplementum
|January 1, 1977
PubMed
Summary

This study evaluated the use of metrizamide in ventriculography for children with suspected obstructive lesions in the brain's ventricular system. The researchers found that metrizamide was most useful for evaluating lesions in the aqueduct or third ventricle. The contrast agent provided clear visualization of these areas, and larger volumes were sometimes needed in cases with significant ventricular dilatation. Polytomography was helpful in some cases but not always required. The study suggests that metrizamide is a suitable contrast agent for pediatric ventriculography, particularly for diagnosing obstructive lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heroin case questions.

British dental journal·2019
Same author

Cause for concern: BDA v GDC.

British dental journal·2018
Same author

The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis.

Cell death discovery·2016
Same author

A randomized clinical study to assess ingestion of dentifrice by children.

Regulatory toxicology and pharmacology : RTP·2016
Same author

Effective half-life of caesium-137 in various environmental media at the Savannah river site.

Journal of environmental radioactivity·2013
Same author

Author's response to: coronary angiography: a silent risk factor for acute kidney injury after cardiopulmonary bypass.

Perfusion·2013

Area of Science:

  • Pediatric neuroimaging techniques
  • Interventional radiology in pediatric medicine

Background:

Prior research has shown that ventriculography is a diagnostic tool for assessing ventricular anatomy in patients with suspected obstructive lesions. It was already known that radiographic contrast agents can delineate cerebrospinal fluid pathways. However, no prior work had resolved the optimal contrast agent for pediatric use. This gap motivated the exploration of metrizamide in children. The safety and efficacy of metrizamide in adults had been established. But the application in pediatric populations remained unclear. This uncertainty drove the need for a study focused on children. The study aimed to address the lack of data on metrizamide in pediatric ventriculography.

Purpose Of The Study:

The aim of the study was to evaluate the use of metrizamide in ventriculography for children. Specifically, the researchers sought to determine its effectiveness in diagnosing obstructive lesions. The motivation stemmed from the need for a safer and more effective contrast agent in pediatric neuroimaging. The study focused on children with suspected ventricular obstruction. The researchers wanted to assess the contrast agent's performance in this population. They also aimed to identify the optimal dose and technique. The study's design allowed for the analysis of metrizamide's utility in pediatric cases. The findings could inform future diagnostic protocols in pediatric neurology.

Keywords:
pediatric neuroimagingcontrast agentventricular obstructiondiagnostic radiology

Frequently Asked Questions

The study suggests that metrizamide is useful for evaluating obstructive lesions in the aqueduct or third ventricle in children.

The dose used was 3 to 6 ml of 200 mg I/ml metrizamide in most cases.

Larger volumes may be needed in cases with significant ventricular dilatation.

Polytomography was found to be useful in many cases but is not always necessary.

The study does not claim that metrizamide is the only effective contrast agent for pediatric ventriculography.

Related Experiment Videos

Main Methods:

The study involved 24 children who underwent ventriculography with metrizamide. The contrast agent used was Amipaque at a concentration of 200 mg I/ml. Doses ranged from 3 to 6 ml in most cases. The procedure was performed to evaluate obstructive lesions in the ventricular system. Polytomography was employed in some cases as an additional diagnostic tool. The researchers assessed the diagnostic yield of metrizamide in these patients. The study design allowed for the comparison of imaging techniques. The focus was on the accuracy of metrizamide in delineating ventricular anatomy.

Main Results:

The study found that metrizamide was most useful in evaluating obstructive lesions in the aqueduct or third ventricle. The contrast agent provided clear visualization of these areas. Larger volumes were required in cases with significant ventricular dilatation. Polytomography was beneficial in many cases but not always necessary. The results suggest that metrizamide is effective in pediatric ventriculography. The optimal dose ranged from 3 to 6 ml in most patients. The study showed that metrizamide can be safely used in children. The findings support the use of metrizamide for diagnosing ventricular obstruction.

Conclusions:

The authors propose that metrizamide is a suitable contrast agent for pediatric ventriculography. The study suggests that it is particularly useful for obstructive lesions in the aqueduct or third ventricle. The findings indicate that larger volumes may be needed in cases with ventricular dilatation. Polytomography was found to be helpful in some cases but not always required. The results support the use of metrizamide in children with suspected ventricular obstruction. The study does not claim that metrizamide is the only effective contrast agent. The authors suggest that further research may explore other agents in pediatric populations. The conclusions are limited to the evidence presented in the study.

The authors suggest that metrizamide is a suitable contrast agent for diagnosing obstructive lesions in children.